Skip to content
OpenCapital
Get started

BioAtla, Inc. BCAB Q4 2024 Annual earnings

Reported March 27, 2025 · After market close

EPS-$0.32Beat by $0.08
EPS estimate-$0.40

Next report

Aug 6, 2026 (In 1 week)
EPS estimate-$8.50

Versus estimates

Revenue

Q4 2025$2.0MBeat by $1.3MQ3 2024$11.0M

Diluted EPS

Q4 2025-$8.00Beat by $4.00Q3 2025-$0.27Beat by $0.04Q2 2025-$0.31Miss by $0.02Q1 2025-$0.29Miss by $0.01
Q4 2024-$0.32Beat by $0.08
Q3 2024-$0.22Beat by $0.12

Ask the moment BioAtla, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did BioAtla, Inc. report Q4 2024 earnings?
BioAtla, Inc. (BCAB) reported Q4 2024 earnings on March 27, 2025 after market close.
What were BioAtla, Inc.'s Q4 2024 revenue and EPS?
BioAtla, Inc. reported eps of $-0.32 for Q4 2024.
Did BioAtla, Inc. beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.40 by $0.08.
Where can I find BioAtla, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-046217) directly on SEC EDGAR. The filing index links above go to sec.gov.